LGALS9 and neoplasm: In accordance with our results, a recent study described a novel immunosuppressive subtype of senescent tumor cells that exerted an inhibitory effect on immune cells, including mast cells, myeloid cells, NK cells, B cells, and T cells via LGALS9 signaling [45].